To present an opportunity that may meet our investment criteria, please provide a non-confidential summary for our consideration at

Our Investment Criteria




Innovative, life changing therapies for diseases with a high degree of unmet medical need and insufficient treatment options

Development Phase



Clinical stage projects with potential to go to market in 3-5 years

Pre-clinical stage projects with predictive animal models and potential to go to market in 5-7 years

Development Strategy



High probability of technical and regulatory success with well defined, FDA validated, clinical efficacy endpoints
Orphan Drug Development



Preference for disease modifying treatments for debilitating orphan diseases  
U.S. Market Potential



In excess of $200M revenue potential
Specialty Sales Force



Up to 100 representatives



Highly experienced management team with an established track record of successful pharmaceutical development